Unknown

Dataset Information

0

JAK inhibitors dampen activation of interferon-stimulated transcription of ACE2 isoforms in human airway epithelial cells.


ABSTRACT: SARS-CoV-2 infection of human airway epithelium activates genetic programs leading to progressive hyperinflammation in COVID-19 patients. Here, we report on transcriptomes activated in primary airway cells by interferons and their suppression by Janus kinase (JAK) inhibitors. Deciphering the regulation of the angiotensin-converting enzyme 2 (ACE2), the receptor for SARS-CoV-2, is paramount for understanding the cell tropism of SARS-CoV-2 infection. ChIP-seq for activating histone marks and Pol II loading identified candidate enhancer elements controlling the ACE2 locus, including the intronic dACE2 promoter. Employing RNA-seq, we demonstrate that interferons activate expression of dACE2 and, to a lesser extent, the genuine ACE2 gene. Interferon-induced gene expression was mitigated by the JAK inhibitors baricitinib and ruxolitinib, used therapeutically in COVID-19 patients. Through integrating RNA-seq and ChIP-seq data we provide an in-depth understanding of genetic programs activated by interferons, and our study highlights JAK inhibitors as suitable tools to suppress these in bronchial cells.

SUBMITTER: Lee HK 

PROVIDER: S-EPMC8172581 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-04-23 | GSE161665 | GEO
2021-04-23 | GSE161664 | GEO
2021-04-23 | GSE161663 | GEO
| PRJNA679038 | ENA
| PRJNA679046 | ENA
| PRJNA679047 | ENA
| S-EPMC7743079 | biostudies-literature
| S-EPMC8321697 | biostudies-literature
2021-02-03 | GSE161917 | GEO
| S-EPMC7252096 | biostudies-literature